Gilead Sciences Inc (MEX:GILD)
MXN 1820 0 (0%) Market Cap: 2.26 Tn Enterprise Value: 2.67 Tn PE Ratio: 109.56 PB Ratio: 6.12 GF Score: 75/100

Q1 2024 Gilead Sciences Inc Earnings Call Transcript

Apr 25, 2024 / 08:30PM GMT
Release Date Price: MXN1121.75 (-1.60%)
Operator

Good afternoon, everyone, and welcome to Gilead's First Quarter 2024 Earnings Conference Call. My name is Rebecca, and I'll be your host for today. In a moment, we'll begin our prepared remarks. (Operator Instructions) I'll now hand the call over to Jacquie Ross, VP, Investor Relations and Corporate Strategic Finance.

Jacquie Ross
Gilead Sciences, Inc. - VP of IR

Thank you, Rebecca. Just after market closed today, we issued a press release with earnings results for the first quarter of 2024. The press release, slides and supplementary data are available on the Investors section of our website at gilead.com.

The speakers on today's call will be our Chairman and Chief Executive Officer, Daniel O'Day; our Chief Commercial Officer, Johanna Mercier; our Chief Medical Officer, Merdad Parsey; and our Chief Financial Officer, Andrew Dickinson. After that, we'll open Q&A where the team will be joined by Cindy Perettie, the Executive Vice President of Kite.

Before we get started, let me remind you that we will be making forward-looking statements.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot